IL-1β, IL-6, IL-8, IL-10, IFN-γ, TNF-α and its relationship with lipid parameters in patients with major depression

[1]  M. Ebesunun,et al.  Elevated plasma homocysteine in association with decreased vitamin B(12), folate, serotonin, lipids and lipoproteins in depressed patients. , 2012, African journal of psychiatry.

[2]  M. Mihanović,et al.  Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  A. Beekman,et al.  More co‐morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[4]  S. Aazami,et al.  Contribution of diet and major depression to incidence of acute myocardial infarction (AMI) , 2010, Lipids in Health and Disease.

[5]  L. Niskanen,et al.  Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men , 2010, European Journal of Epidemiology.

[6]  G. Eby,et al.  Magnesium for treatment-resistant depression: a review and hypothesis. , 2010, Medical hypotheses.

[7]  B. Morasco,et al.  Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies , 2010, Neurobiology of Disease.

[8]  P. Das,et al.  Elevated total cholesterol in severely depressed patients: Role in cardiovascular risk? , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[9]  L. Niskanen,et al.  Serum chemokine levels in major depressive disorder , 2010, Psychoneuroendocrinology.

[10]  J. Vrzalová,et al.  Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression. , 2010, Physiological research.

[11]  A. A. Farooqui.  Lipid Mediators in the Neural Cell Nucleus: Their Metabolism, Signaling, and Association with Neurological Disorders , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[12]  D. Ramji,et al.  Interferon gamma: a master regulator of atherosclerosis. , 2009, Cytokine & growth factor reviews.

[13]  M. Fresno,et al.  IFN-γ-Induced TNF-α Expression Is Regulated by Interferon Regulatory Factors 1 and 8 in Mouse Macrophages1 , 2008, The Journal of Immunology.

[14]  F. Holsboer,et al.  Depression, comorbidities and the TNF-α system , 2008, European Psychiatry.

[15]  M. Maes.  The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. , 2008, Neuro endocrinology letters.

[16]  D. F. Swaab,et al.  The stress system in depression and neurodegeneration: Focus on the human hypothalamus , 2008, Brain Research Reviews.

[17]  F. Hohagen,et al.  Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique , 2008, Psychosomatic medicine.

[18]  M. Fresno,et al.  IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. , 2008, Journal of immunology.

[19]  M. Rodríguez-Moran,et al.  Depressive symptoms and hypomagnesemia in older diabetic subjects. , 2007, Archives of medical research.

[20]  K. Stokes,et al.  T-Cell–Derived Interferon-γ Contributes to Arteriolar Dysfunction During Acute Hypercholesterolemia , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Chien-Te Lee,et al.  T‐helper 1/T‐helper 2 cytokine imbalance and clinical phenotypes of acute‐phase major depression , 2007, Psychiatry and clinical neurosciences.

[22]  C. Tsigos,et al.  Stress, Visceral Obesity, and Metabolic Complications , 2006, Annals of the New York Academy of Sciences.

[23]  C. Pantelis,et al.  Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. , 2006, The Australian and New Zealand journal of psychiatry.

[24]  Thomaz Cruz,et al.  Deficiência de magnésio e resistência à insulina em pacientes com diabetes mellitus tipo 2 , 2005 .

[25]  Evette Ludman,et al.  The association of comorbid depression with mortality in patients with type 2 diabetes. , 2005, Diabetes care.

[26]  J. Kiecolt-Glaser,et al.  Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.

[27]  G. Ice,et al.  Blood Glucose Correlations With Depression, Body Habitus and Caregiving Status in the Elderly Kenyan Luo Grandparents , 2005, The Journal of the American Osteopathic Association.

[28]  T. Cruz,et al.  [Magnesium deficiency and insulin resistance in patients with type 2 diabetes mellitus]. , 2005, Arquivos brasileiros de endocrinologia e metabologia.

[29]  M. Maj,et al.  Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. , 2004, Journal of affective disorders.

[30]  M. Maj,et al.  Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. , 2004, Journal of affective disorders.

[31]  C. O'connor,et al.  Depression and cardiovascular disease: mechanisms of interaction , 2003, Biological Psychiatry.

[32]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[33]  S. Kara,et al.  Depression, cytokines and immune system , 2003 .

[34]  J. Reggers,et al.  [Lipids, depression and suicide]. , 2003, L'Encephale.

[35]  A. Johnson,et al.  Biological mechanisms in the relationship between depression and heart disease , 2002, Neuroscience & Biobehavioral Reviews.

[36]  E. Faist,et al.  Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection , 2002, Critical care.

[37]  S. Sur,et al.  CCL7 and CXCL10 Orchestrate Oxidative Stress-Induced Neutrophilic Lung Inflammation1 , 2002, The Journal of Immunology.

[38]  K. Nishioka,et al.  Stress response, tachykinin, and cutaneous inflammation. , 2001, The journal of investigative dermatology. Symposium proceedings.

[39]  E. Caine,et al.  Depression, Medical Illness, and Interleukin-1β in Older Cardiac Patients , 2001, International journal of psychiatry in medicine.

[40]  Dolores Rafter.  Biochemical markers of anxiety and depression , 2001, Psychiatry Research.

[41]  T. Pollmächer,et al.  Mediators of Inflammation and Their Interaction with Sleep , 2001, Annals of the New York Academy of Sciences.

[42]  S. Melmed,et al.  Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. , 2000, The Journal of clinical investigation.

[43]  M. Kurrer,et al.  Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. G. Almeida-Montes,et al.  Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. , 2000, Journal of psychiatry & neuroscience : JPN.

[45]  J. Lönnqvist,et al.  Association of low serum total cholesterol with major depression and suicide , 1999, British Journal of Psychiatry.

[46]  R. Dantzer,et al.  Cytokines, stress, and depression. Conclusions and perspectives. , 1999, Advances in experimental medicine and biology.

[47]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[48]  A. Turnbull,et al.  Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. , 1999, Physiological reviews.

[49]  P. Dalal,et al.  SERUM LIPIDS : NEW BIOLOGICAL MARKERS IN DEPRESSION ? , 1998, Indian journal of psychiatry.

[50]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[51]  K. Feingold,et al.  Beneficial effects of cytokine induced hyperlipidemia. , 1998, Zeitschrift für Ernährungswissenschaft.

[52]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[53]  H. Meltzer,et al.  Lower serum high‐density lipoprotein cholesterol (HDL‐C) in major depression and in depressed men with serious suicidal attempts: relationship with immune‐inflammatory markers , 1997, Acta psychiatrica Scandinavica.

[54]  S. Olusi,et al.  Serum lipid concentrations in patients with major depressive disorder , 1996, Biological Psychiatry.

[55]  R. Weizman,et al.  Cytokine production in major depressed patients before and after clomipramine treatment , 1994, Biological Psychiatry.

[56]  H. Meltzer,et al.  Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? , 1993, The American journal of psychiatry.

[57]  R. Natarajan,et al.  Intracellular Free Magnesium Deficiency Plays a Key Role in Increased Platelet Reactivity in Type II Diabetes Mellitus , 1992, Diabetes Care.

[58]  R. Schiffer.  Depressive Syndromes Associated with Diseases of the Central Nervous System , 1990, Seminars in neurology.

[59]  J. Amsterdam,et al.  Insulin resistance after oral glucose tolerance testing in patients with major depression. , 1988, The American journal of psychiatry.

[60]  T. Moore,et al.  Mediators of inflammation. , 1985, Seminars in arthritis and rheumatism.

[61]  G. Oxenkrug,et al.  Is serum cholesterol a biological marker for major depressive disorder? , 1983, The American journal of psychiatry.